Bevacizumab for Cerebral Radionecrosis: A Single-Center Experience.

Seth Andrew Climans Ronald C RamosPaola A JablonskaDavid B ShultzWarren P Mason

Published in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2022)

Although bevacizumab is commonly prescribed for cerebral radionecrosis, in our retrospective cohort, the clinical benefits were modest and there was significant toxicity.

Keyphrases

subarachnoid hemorrhage
metastatic colorectal cancer
cerebral ischemia
oxidative stress
cross sectional
cerebral blood flow